J Korean Ophthalmol Soc.  2009 Dec;50(12):1780-1788. 10.3341/jkos.2009.50.12.1780.

Recurrence Rates of Amniotic Membrane Transplantation, Conjunctival Autograft and Conjunctivolimbal Autograft in Primary Pterygium

Affiliations
  • 1Department of Ophthalmology, Daegu Fatima Hospital, Daegu, Korea. djoph2540@yahoo.co.kr

Abstract

PURPOSE
To compare the recurrence rates and complications with amniotic membrane transplantation (fibrin glue group and suture group), conjunctival autograft and conjunctivolimbal autograft in excision of primary pterygium.
METHODS
Among 121 eyes of 115 patients with a minimum follow-up period of 12 months, 33 eyes of 31 patients underwent amniotic membrane transplantation with fibrin glue (Group 1) and 29 eyes of 28 patients underwent amniotic membrane transplantation with sutures (Group 2). Twenty-eight eyes of 26 patients underwent conjunctival autograft (Group 3), and 31 eyes of 30 patients underwent conjunctivolimbal autograft (Group 4). Recurrence rates and complications were evaluated retrospectively.
RESULTS
With a minimum of 12 months of follow-up, conjunctival recurrence was noted in seven eyes (21.2%) and six eyes (20.7%) in Group 1 and Group 2, respectively. Corneal recurrence occurred in one eye (3.0%) in Group 1 and in three eyes (10.3%) in Group 2 and no conjunctival or corneal recurrence were noted in Group 3 or Group 4. There was a statistically significant difference in conjunctival recurrence rates (p=0.003), but not in corneal recurrence rates (p=0.089) among the four groups.
CONCLUSIONS
Although amniotic membrane transplantation preserved the superotemporal conjunctiva and was a technically easy procedure, it had high conjunctival recurrence rates. Conjunctival autograft and conjunctivolimbal autograft are technically demanding and time consuming, but they are more effective in preventing conjunctival recurrence compared with amniotic membrane transplantation.

Keyword

Amniotic membrane transplantation; Conjunctival autograft; Conjunctivolimbal autograft; Pterygium; Recurrence rates

MeSH Terms

Adhesives
Amnion
Conjunctiva
Eye
Fibrin Tissue Adhesive
Follow-Up Studies
Humans
Pterygium
Recurrence
Retrospective Studies
Sutures
Transplants
Adhesives
Fibrin Tissue Adhesive

Figure

  • Figure 1. Classification of pterygium. (A) Grade T1 (atrophic), episcleral vessels are unobscured. (B) Grade T2 (intermediate), episcleral vessels are partially obscured. (C) Grade T3 (fleshy), episcleral vessels are totally obscured.

  • Figure 2. Grading of recurrence after pterygium surgery. (A) Grade 0, normal appearance of the operated site. (B) Grade 1, fine episcleral vessels in the excised area. (C) Grade 2, fibrovascular tissue in the excised area, reaching to the limbus, but not invading the cornea (conjunctival recurrence). (D) Grade 3, fibrovascular tissue invading the cornea (corneal recurrence).

  • Figure 3. Complications after pterygium surgery. (A) Sub-AM hemorrhage. (B) Sub-conjunctival graft hemorrhage. (C) Dornor site scarring. (D) Granuloma. (E) Dornor site limbal stem cell deficiency. (F) Wound gaping (yellow star).


Cited by  3 articles

Analysis of Donor-site Complications after Conjunctivo-limbal Autograft to Treat Pterygium
Min Gu Huh, Dae Jin Park
J Korean Ophthalmol Soc. 2019;60(2):109-118.    doi: 10.3341/jkos.2019.60.2.109.

Recurrence Rates of Conjunctival Autograft Transplantation With Aminiotic Membrane Transplantation in Primary Pterygium Surgery
Jong Wan Kim, Jaehong Ahn, Koung Hoon Kook, Hongseok Yang
J Korean Ophthalmol Soc. 2011;52(2):163-168.    doi: 10.3341/jkos.2011.52.2.163.

Surgical Outcome of Primary Pterygium Excision with Conjunctival Autograft
Dong Ik Kim, Mee Kum Kim, Won Ryang Wee, Joo Youn Oh
J Korean Ophthalmol Soc. 2015;56(6):856-862.    doi: 10.3341/jkos.2015.56.6.856.


Reference

References

1. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol. 2001; 119:695–706.
2. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol. 1999; 128:280–7.
Article
3. Dadeya S, Malik KP, Gullian BP. Pterygium surgery: conjunctival rotation autograft versus conjunctival autograft. Ophthalmic Surg Lasers. 2002; 33:269–74.
Article
4. Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997; 115:1235–40.
Article
5. Al Fayez MF. Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 2002; 109:1752–5.
Article
6. Gris O, Guell JL, del Campo Z. Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology. 2000; 107:270–3.
Article
7. Shimazaki J, Yang HY, Tsubota K. Limbal autograft transplantation for recurrent and advanced pterygia. Ophthalmic Surg Lasers. 1996; 27:917–23.
Article
8. Ti SE, Tseng SC. Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr Opin Ophthalmol. 2002; 13:204–12.
Article
9. Solomon A, Pires RT, Tseng SC. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001; 108:449–60.
Article
10. Ma DH, See LC, Hwang YS, Wang SF. Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea. 2005; 24:141–50.
Article
11. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997; 104:974–85.
Article
12. Lee SB, Li DQ, Tan DT, et al. Suppression of TGF-β signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res. 2000; 20:325–34.
Article
13. Jurgenliemk-Schulz IM, Hartman LJ, Roesink JM, et al. Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys. 2004; 59:1138–47.
14. Liddy BS, Morgan JF. Triethylene thiophosphoramide (thio-tepa) and pterygium. Am J Ophthalmol. 1966; 61:888–90.
15. Segev F, Jaeger-Roshu S, Gefen-Carmi N, Assia EI. Combined mitomycin C application and free flap conjunctival autograft in pterygium surgery. Cornea. 2003; 22:598–603.
Article
16. Sharma A, Gupta A, Ram J, Gupta A. Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Ophthalmic Surg Lasers. 2000; 31:301–7.
Article
17. Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea. 2004; 23:458–63.
Article
18. Kwak DY, Bae MC, Lee JK, Park DJ. Pterygium surgery: wide excision with conjunctivolimbal autograft. J Korean Ophthalmol Soc. 2008; 49:205–12.
Article
19. Kwak DY, Lee JK, Park DJ. Pterygium surgery: wide excision with amniotic membrane transplantation using fibrin glue. J Korean Ophthalmol Soc. 2008; 49:213–21.
Article
20. Ahn DG, Auh SJ, Choi YS. The clinical results of limbal conjunctival autograft transplantation with intraoperative mitomycin c application for recurrent pterygia. J Korean Ophthalmol Soc. 1999; 40:2443–9.
21. Guler M, Sobaci G, Ilker S, et al. Limbal-conjunctival autograft transplantation in cases with recurrent pterygium. Acta Ophthalmol (Copenh). 1994; 72:721–6.
22. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985; 92:1461–70.
Article
23. Marticorena J, Rodriguez-Ares MT, Tourino R, et al. Pterygium surgery: conjunctival autograft using a fibrin adhesive. Cornea. 2006; 25:34–6.
Article
24. Jang JH, Choi TH. The effect of amniotic membrane transplantation for pterygium excision. J Korean Ophthalmol Soc. 2005; 46:597–604.
25. Ti SE, Chee SP, Dear KB, Tan DT. Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium. Br J Ophthalmol. 2000; 84:385–9.
Article
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr